Lucy Scientific Discovery Inc. LSDI NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score

21/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Lucy Scientific Discovery Inc. (LSDI) generated $-318.34K in operating cash flow for quarter ending 2023-12-31. After capital expenditures of $944.00, free cash flow was $-317.39K.

Free cash flow margin was -3277.5% of revenue. Cash conversion ratio was 0.24x, suggesting some earnings are non-cash.

Criteria supported by this page:

HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
MOAT (32/100, Fail) — limited free cash flow weakens the competitive position
INCOME (10/100) — Cash conversion ratio was 0.24x suggests some earnings are non-cash items

Overall SharesGrow Score: 20/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

21/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

HEALTH

50/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

32/100

Proven by this page

✗

GROWTH

15/100

→ Income

✗

INCOME

10/100

→ Income

Lucy Scientific Discovery Inc. Cash Flow History

Metric	TTM	Q2 FY2024	Q1 FY2024	Q4 FY2023	Q3 FY2023
Operating Cash Flow	$-5.5M	$-318.34K	$-1.29M	$-1.86M	$-2.03M
Capital Expenditure	$-421.28K	$944.00	$-123K	$-299.22K	$0.00
Free Cash Flow	$-5.92M	$-317.39K	$-1.41M	$-2.16M	$-2.03M